By drug type/brand type, the Semaglutide (Ozempic, Wegovy, Rybelsus) segment held the largest share of 49% in the market in 2025
The PlexusDx Precision Peptide Genetic Test ($298) maps 14 metabolic pathways and identifies genetic variants like GLP1R rs6923761 that influence your tirzepatide response and microbial sensitivity
Additionally, their under-development triple agonist, Retatrutide, has shown unprecedented weight loss effects in phase 2 clinical trials
Contraindicated in cardiovascular disease, uncontrolled hypertension, concurrent nitrate use, and pregnancy
Serena Russum, ND, CNCB Guest expert
What should meals actually look like while you're on a GLP-1